Carregando...
Measuring differential treatment benefit across marker specific subgroups: the choice of outcome scale
Clinical and epidemiological studies of anticancer therapies increasingly seek to identify predictive biomarkers to obtain insights into variation in treatment benefit. For time to event endpoints, a predictive biomarker is typically assessed using the interaction between the biomarker and treatment...
Na minha lista:
| Publicado no: | Contemp Clin Trials |
|---|---|
| Principais autores: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5568905/ https://ncbi.nlm.nih.gov/pubmed/28254404 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cct.2017.02.007 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|